Morgan Stanley’s Genesis Healthcare, Inc. GEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,090
Closed -$1K 7655
2020
Q4
$1K Buy
2,090
+2,000
+2,222% +$1.01K ﹤0.01% 7014
2020
Q3
$0 Sell
90
-40,447
-100% -$29.1K ﹤0.01% 6916
2020
Q2
$28K Buy
40,537
+19,969
+97% +$16.1K ﹤0.01% 5905
2020
Q1
$18K Sell
20,568
-94,263
-82% -$135K ﹤0.01% 5854
2019
Q4
$189K Buy
114,831
+91,041
+383% +$137K ﹤0.01% 5438
2019
Q3
$26K Buy
23,790
+21,461
+921% +$24.8K ﹤0.01% 5940
2019
Q2
$2K Sell
2,329
-172,247
-99% -$219K ﹤0.01% 6493
2019
Q1
$252K Sell
174,576
-122,970
-41% -$182K ﹤0.01% 4945
2018
Q4
$350K Sell
297,546
-12,813
-4% -$19K ﹤0.01% 5020
2018
Q3
$420K Buy
310,359
+117,615
+61% +$186K ﹤0.01% 5096
2018
Q2
$441K Buy
192,744
+93,873
+95% +$181K ﹤0.01% 5182
2018
Q1
$149K Buy
98,871
+4,707
+5% +$5.51K ﹤0.01% 5588
2017
Q4
$72K Buy
94,164
+35,497
+61% +$31.7K ﹤0.01% 5734
2017
Q3
$68K Sell
58,667
-132,519
-69% -$167K ﹤0.01% 5688
2017
Q2
$333K Buy
191,186
+13,473
+8% +$28.6K ﹤0.01% 5043
2017
Q1
$469K Buy
177,713
+10,034
+6% +$36K ﹤0.01% 4877
2016
Q4
$713K Buy
167,679
+159,289
+1,899% +$525K ﹤0.01% 4697
2016
Q3
$22K Buy
8,390
+7,952
+1,816% +$18.3K ﹤0.01% 5892
2016
Q2
$1K Sell
438
-5,457
-93% -$11.1K ﹤0.01% 6460
2016
Q1
$14K Sell
5,895
-3,936
-40% -$8.9K ﹤0.01% 6039
2015
Q4
$34K Sell
9,831
-2,943
-23% -$14.1K ﹤0.01% 5862
2015
Q3
$78K Sell
12,774
-2,120
-14% -$14.4K ﹤0.01% 5544
2015
Q2
$99K Sell
14,894
-101,794
-87% -$687K ﹤0.01% 5597
2015
Q1
$830K Buy
+116,688
New +$880K ﹤0.01% 4269

Other funds holding GEN

Morgan Stanley's GEN Position: Q1 2021 in Review

Morgan Stanley sold out of Genesis Healthcare, Inc. (GEN) in Q1 2021, closing a stake of 2,090 shares — an estimated $1K sold.

Morgan Stanley first reported a position in GEN in Q1 2015 and held it in 24 quarters. The position peaked at $830K in Q1 2015. 8 funds tracked by Wall St. Rank hold GEN as of Q1 2021.

  • Morgan Stanley reported no remaining Genesis Healthcare, Inc. position as of Q1 2021 after selling out during the quarter.
  • Morgan Stanley sold 2,090 Genesis Healthcare, Inc. shares in Q1 2021, an estimated $1K.
  • Morgan Stanley first reported a position in Genesis Healthcare, Inc. in Q1 2015 and held it in 24 quarters.
  • Morgan Stanley's Genesis Healthcare, Inc. position peaked at $830K in Q1 2015.
  • 8 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q1 2021.

Based on Morgan Stanley's 13F filing for Q1 2021, filed 17 May 2021.